Clinical Trials · NCT00191425
2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal Osteoporosis
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- Eli Lilly and Company
- Enrollment
- 810
- Start date
- Aug 2002
- Locations
- 1 site, Germany
- Primary endpoint
- Lumbar spine BMD after 24 months.